)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
ViroGates
ViroGates (VIRO) investor relations material
ViroGates Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary7 May, 2026
Executive summary
Revenue grew 8% year-over-year in Q1 2026, reaching TDKK 1,303, with net loss improving by 6% to TDKK -2,611 compared to Q1 2025.
Longevity and preventive health segments became the largest revenue contributors, surpassing research for the first time.
Strategic collaborations advanced, including a De Novo FDA application with Sobi and product development with GENSPEED Biotech.
Cash and cash equivalents nearly doubled year-over-year to TDKK 22,280, supporting ongoing investments.
Financial highlights
Gross profit increased 83% year-over-year to TDKK 976, while operating loss rose 4% to TDKK -2,871.
Operating expenses increased 17% to TDKK -3,846, mainly due to higher R&D costs.
Equity ratio improved to 63% from 50% in Q1 2025.
Cash flows from operating activities were negative at TDKK -3,735, a significant increase in outflow compared to Q1 2025.
Outlook and guidance
Full-year 2026 guidance maintained: revenue of DKK 6–7 million and EBIT of DKK -10 to -12 million.
US longevity market launch preparations ongoing, with timing uncertainty reflected in guidance.
Longevity segment expected to drive future growth, though current contributions remain modest.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ViroGates
- Revenue up 8%, net loss down 28%, and regulatory progress positions for future growth.VIRO
Q4 202527 Mar 2026 - Revenue fell 11% as hospital sales lagged, but new segments and US FDA progress show promise.VIROQ2 20241 Feb 2026
- Revenue fell 29% as losses widened and focus shifted to longevity diagnostics and US expansion.VIROQ3 202415 Jan 2026
- Revenue fell 12% and net loss deepened as focus shifted to US longevity and health markets.VIROQ4 202426 Dec 2025
- Net loss narrowed 23% on flat revenue as focus shifted to longevity clinics and recurring customers grew.VIROQ1 202524 Nov 2025
- Q3 revenue jumped 49% year-over-year, narrowing net loss and accelerating longevity market focus.VIROQ3 202510 Nov 2025
- Revenue fell 18% in H1 2025, but improved margins and new market focus support future growth.VIROQ2 202521 Aug 2025
Next ViroGates earnings date
Q2 202620 Aug, 2026
ViroGates
Next ViroGates earnings date
Q2 202620 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage